220 research outputs found
Un nuovo capitolo nella saga Ilva: commento al decreto-legge n. 2 del 2023
No full textL’articolo ha analizzato le principali novità giuridiche del decreto-legge n. 2 del
2023, riguardante l’acciaieria Ilva di Taranto. Il decreto-legge n. 2 del 2023 ha designato l’Ilva
come «impianto di interesse strategico nazionale» e ha introdotto nuove misure legislative per
garantirne il continuo funzionamento. Per dare una definizione del concetto di «impianto di
interesse strategico nazionale», è stato necessario contestualizzare le disposizioni del decreto-legge
nelle più ampie vicende dell’Ilva. Dopodichè, il decreto-legge n. 2 del 2023 ha permesso il
completamento dell’acquisizione dello stabilimento da parte dello Stato tramite Invitalia,
un’impresa sottoposta al controllo del Ministero dell’Economia e delle Finanze. Lo studio ha
esaminato le implicazioni legali e costituzionali del coinvolgimento dello Stato nella gestione
dell’Ilva Taranto, soprattutto alla luce della nuova formulazione dell’art. 41 Cost. Per concludere,
sempre il decreto-legge n. 2 del 2023 ha introdotto un nuovo scudo penale, con l’obiettivo di
proteggere da procedimenti penali gli individui coinvolti nel garantire il continuo funzionamento
dell’impianto strategico, a patto che vi sia un’adesione alle disposizioni del «provvedimento che
autorizza la prosecuzione dell’attività». Sono state esaminate le implicazioni e le preoccupazioni
costituzionali legate allo scudo penal
Chi è il giudice a quo? Il caso particolare dell’Autorità Garante della Concorrenza e del Mercato
No full textCommento introduttivo alla sentenza n. 13/2019 della Corte Costituzional
Il rispetto dei principi dello stato di diritto e la legittimità del regolamento europeo sulla "condizionalità" per accedere ai fondi di Next Generation
No full textIl commento riguarda le sentenze della Corte di Giustizia del 16 febbraio 2022 sul ricorso di annullamento del regolamento n. 2092 del 2020
Paysandisia archon: Taxonomy, distribution, biology and life cycle
No full textThe taxonomic position of the family Castniidae within the order Lepidoptera has changed over time. Initially, it was classified in the superfamily Sesioidea, and then it was grouped in a large assemblage including the Cossoidea, Sesioidea, and Zygaenoidea. Recent studies have included it in the superfamily Cossoidea. In Europe, the palm borer moth (PBM) Paysandisia archon is the only species of the Castniidae. This moth, native to South America (Argentina and Uruguay), was first reported in Europe (France and Spain) in 2001, but it is believed to have been introduced before 1995 on palm trees imported from Argentina. Since then, the moth has been reported in Belgium, Bulgaria, Cyprus Island, Croatia, the Czech Republic, Denmark, France, Greece, Italy, Slovenia, Spain, Switzerland, and the United Kingdom. All known hosts are palms (family Arecaceae). The moth appears to have a wide host range, including the native Mediterranean palms but also exotic species, threatening ornamental and patrimonial palms, as well as date palms in North Africa. In Europe, the adult moths are active during the hottest part of sunny days, from mid-May to September–October, with a peak during June and July. PBM overwinter as larvae. Cocoons can be found from mid-March to mid-September. During the summer, all of the developmental stages of the moth (egg, larva, pupa, and adult) can be observed. Recent research has aimed to provide a more comprehensive understanding of the PBM's biology and host palm tree range under European Mediterranean conditions, to fill the knowledge gaps, support decisions for risk assessment, and improve monitoring, management, and regulation
Obstetric complications and clinical presentation in first episode of psychosis
No full textVerdolini N, Mezquida G, Valli I, Garcia-Rizo C, Cuesta M, Vieta E, Bioque M, Lobo A, González-Pinto A, Pina-Camacho L, Corripio I, Garriga M, Baeza I, Martínez-Sadurní L, Bitanihirwe B, Cannon M, Bernardo M; PEPs GROU
Author Correction: Systematic review of the outcomes and trade-offs of ten types of decarbonization policy instruments (Nature Climate Change, (2021), 10.1038/s41558-020-00971-x)
No full textIn the version of this Analysis originally published online, in the third sentence of the Data availability section, the link ‘https://dpet.innopahts.eu/’ was incorrect; it should have been ‘http://dpet.innopaths.eu/#/’. All versions of the Analysis have been corrected
Searching for factors associated with the “Revolving Door phenomenon” in the psychiatric inpatient unit: A 5-year retrospective cohort study
No full textThe revolving door (RD) phenomenon refers to subjects who undergo frequent rehospitalizations in psychiatric units. The main aim of this study was to analyze clinical factors associated with RD in acute inpatient psychiatric ward. In a 5-year cohort study, subjects hospitalized three or more times in 12 months (revolving door subjects-RDS) were identified. A total of 1,324 subjects were hospitalized. RDS represented 6.3% (n = 84) of the entire sample with a total of 337 RD hospitalizations (revolving door hospitalizations-RDH) (16.7% of all admissions). RDS were younger, unmarried, with comorbid substance related disorders, with mood or psychotic disorders and affected by comorbid medical conditions. After controlling for age, sex and marital status, the most strongly associated variable with RDH was the comorbidity between mood and substance use disorders. Other associated factors were the presence of a comorbid medical condition and a longer length of stay. The commitment to community residential facilities and the treatment with a first generation long-acting antipsychotic were also associated with RDH. On the contrary, admissions to the psychiatric unit for manic/hypomanic episode or for self-directed harmful behavior were inversely associated with RDH. Attention should be given to these clinical variables in order to reduce RD
Not the same old madness: Evaluating the clinical profile of the “schizophrenia spectrum” disorders
No full textIntroductionThe “schizophrenia spectrum” concept allowed better identifying the psychopathology underpinning disorders including schizophrenia, schizoaffective disorder (SZA) and cluster A personality disorders (PD).AimsTo compare the clinical portrait of the schizophrenia spectrum disorders, focusing on the impact of the affective dimension.MethodsInpatients at the acute psychiatric ward of Perugia (Umbria-Italy) were evaluated with the structured clinical interview for DSM-IV Axis I and Axis II disorders and diagnosed with a “schizophrenia spectrum” disorder according to DSM-IV-TR. The clinical evaluation was conducted using the positive and negative syndrome scale (PANSS). Pearson correlations of the different subscales in the three groups and between the negative scales with the affective symptom “depression” were conducted.ResultsThe sample consisted of 72 inpatients (schizophrenia 55.6%, SZA 20% and cluster A PD 19.4%). The negative and the general psychopathology scales directly correlated at different degrees in the three groups (schizophrenia: r = 0.750; P < 0.001; SZA: r = 0.625, P = 0.006; cluster A PD: r = 0.541, P = 0.046). The symptom “depression” directly correlated with 5 out of 7 negative symptoms: blunted affect (r = 0.616, P < 0.001), emotional withdrawal (r = 0.643, P < 0.001), poor rapport (r = 0.389, P = 0.001), passive/apathetic social withdrawal (r = 0.538, P < 0.001), lack of spontaneity & flow of conversation (r = 0.399, P = 0.001).ConclusionsOur study confirmed the existence of the “schizophrenia spectrum” with combined different disorders lying on a continuum in which negative symptoms mainly correlated with the psychopathological functioning. Noteworthy, the symptoms of the negative scale strongly correlated with the “depression” symptom, underlying the impact of the affective symptoms on the severity of the “schizophrenia spectrum” disorders.Disclosure of interestThe authors have not supplied their declaration of competing interest.</jats:sec
Oral versus long-acting injectable antipsychotics: Hospitalisation rate of psychotic patients discharged from an Italian Psychiatric Unit
No full textObjective: The primary aim is to verify the efficacy of long-acting injectable (LAI) and oral antipsychotics (AP) in terms of rehospitalisation rate of patients with psychotic disorders. The second aim is to evaluate socio-demographic and clinical differences in patients that were re-hospitalised after the index discharge compared to patients that were not re-hospitalised. Finally, socio-demographic and clinical differences of re-hospitalised patients that were prescribed at discharge with oral or LAI AP were analysed. Methods: A retrospective observational study including all patients discharged with diagnosis of psychotic disorders from July 2011 to July 2013 was conducted. Patients discharged with LAI or with oral AP were included. Re-hospitalisations occurred during a followup period of 24 months after the index discharge were considered. Chi-square test or Student's t-test were used for comparisons. Odds ratios (OR) and 95% confidence intervals (CI) for the incidence of re-hospitalisation for LAI or oral AP were provided. Results: No significant differences between LAI and oral AP in terms of re-hospitalisation rate in a 24-month period were found. Clinical and socio-demographic characteristics did not significantly differ between the groups. Conclusions: LAI seemed to be similar to oral AP in terms of prevention of re-hospitalisation in psychotic patients
- …
